New Research Aimed at Promoting Better Patient Adherence to HIV Medications

Paul Drain—an Associate Professor in the Department of Global Health, Medicine and Epidemiology at the University of Washington—and his research team have received a new grant from the CoMotion Innovation Gap Fund, a program intended to help bridge the gap between academic research grants and the level of development needed to obtain investment. Drain’s project is titled “Rapid test for measuring adherence to antiretroviral therapy and pre-exposure prophylaxis”.  

US Hospitals Could Be Overwhelmed in the Second Week of April (IHME)

In a forecast based on new data analyses, researchers find demand for ventilators and beds in US hospital intensive care units (ICUs) will far exceed capacity for COVID-19 patients as early as the second week of April. Deaths related to the current wave of COVID-19 in the US are likely to persist into July, even assuming people protect themselves and their communities by strongly adhering to social distancing measures and by taking other precautions advised by public health officials. 

DGH Researchers Receive CFAR International Infrastructure Awards

The University of Washington/Fred Hutch Center for AIDS Research (CFAR) recently announced the recipients of their International Infrastructure Awards. Geoffrey Gottlieb (Adjunct Professor of Global Health), John Kinuthia (Affiliate Associate Professor), Rose Bosire (Clinical Research Scientist/Global Health Fellow), and Sylvia LaCourse (Assistant Professor) each received awards.

Seattle Team Gets Funding to Start Human Trials of Potentially Groundbreaking Coronavirus Treatment (Seattle Times - Quotes Corey Casper)

Seattle’s Infectious Disease Research Institute has received seven-figure funding to begin human trials on a potentially groundbreaking novel coronavirus treatment.

The study could launch within weeks, take about 11 months to complete, and enroll about 100 patients diagnosed with a COVID-19 infection that’s causing moderate to severe pneumonia. It would deploy cancer-fighting NK-cells as an immunotherapy treatment for the coronavirus rather than the current approach of antiviral medication.

Coronavirus Q&A with MPH Alumna Patricia García (Publimetro)

Patricia García, Peru's former Minister of Health and an Affiliate Professor of Global Health at the University of Washington, spoke to Publimetro in her home country of Peru about the country's response to the coronavirus pandemic. García received a Masters of Public Health at UW and is also a professor at the School of Public Health at Cayetano Heredia University in Lima, Peru. Her areas of expertise include epidemiology, infectious diseases, and implementation science.

The following interview has been translated from Spanish. 

UW Spring Quarter Classes will be Held Remotely

This message was sent to students on all University of Washington campuses.

Dear Students,

Today we are announcing our path forward for spring quarter 2020. Thank you, again, for your perseverance and goodwill as we navigate difficult, uncertain and rapidly changing times in our country and the world.

Classes and instruction to be offered remotely throughout spring quarter

Lessons from Africa on How to Fight an Infection (UW Medicine - Quotes Ruanne Barnabas)

In parts of Africa, where the HIV rate is 36 percent, researchers tested out a simple idea: They made access to care easier for people living with a chronic condition.

In a nearly three-year study in South Africa and Uganda, researchers used mobile vans in five communities to dispense care and treatment to 1,315 people living with HIV and not on antiretroviral treatment.

The randomized controlled trial, conducted between May 2016 and March 2019, found that viral suppression was 74 percent, compared to 63 percent for those seen in a clinic.

Pages